GAUGING THE CLINICAL COURSE OF DRUG-RESISTANT EPILEPSY: A RETROSPECTIVE ANALYSIS OF PROGRESSION FROM SEIZURES TO STATUS EPILEPTICUS
DOI:
https://doi.org/10.37547/Keywords:
Drug Resistant Epilepsy, Focal to bilateral tonic-clonic, cystic cerebral arachnoiditis, congenital and structural etiologies.Abstract
Epilepsy is the common neurological condition which effects the people of all age. There are around 50 million people suffering with epilepsy in this world.
Downloads
References
1.Huang J., Li, H.Y., Xu, P., Ren, X. and Lin, S. (2025) Effects of surgical ventricular entry on gliomas invading the thalamus: clinical outcomes and economic burdens, World Neurosurg., 196, p. 123731. Doi:10.1016/j.wneu.2025.123729 https://doi.org/10.1016/j.wneu.2025.123729
2.Bastos F. and Cross JH. (2020) ‘Epilepsy’, in Handbook of Clinical Neurology, Vol. 174. Amsterdam: Elsevier, pp. 137–158. doi:10.1016/B978-0-444-64148-9.00011-9. https://doi.org/10.1016/B978-0-444-64148-9.00011-9
3. Xu MY. (2019) ‘Poststroke seizure: optimising its management’, Stroke Vasc. Neurol., 4(1), pp. 48–56. Doi:10.1136/svn-2018-000175. https://doi.org/10.1136/svn-2018-000175
4.Ryvlin P., et al. (2011) ‘Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials’, Lancet Neurol., 10(11), pp. 961–968. doi:10.1016/S1474-4422(11)70193-4. https://doi.org/10.1016/s1474-4422(11)70193-4
5.Melton JV., et al. (2002) ‘Alphavirus 6K proteins form ion channels’, J. Biol. Chem., 277(49), pp. 46923–46931. Doi:10.1074/jbc.M207847200 https://doi.org/10.1074/jbc.m207847200
6.Schuele SU., Busch, R.M., Frauscher, B., Gnatkovsky, V., Hamer, H.M., Jehi, L., Kanner, A.M., Ramantani, G., Rüber, T., Schulze-Bonhage, A., Surges, R. and Wadi, L. (2025) ‘Seminars in epileptology: presurgical epilepsy evaluation’, Epileptic Disord., 27(6), pp. 1105–1147. Doi:10.1002/epd2.70105
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles published in this journal are licensed under the Creative Commons Attribution 4.0 International License (CC-BY 4.0). Under this license:
- Share: Copy and redistribute the material in any medium or format
- Adapt: Remix, transform, and build upon the material for any purpose, including commercially
Attribution required: You must give appropriate credit, provide a link to the license, and indicate if changes were made.
License URL: https://creativecommons.org/licenses/by/4.0/
Authors retain copyright of their work while granting the journal first publication rights.